Second WHO Global Summit Aims to Transform Traditional Medicine Through Evidence and Innovation
December 19, 2025
Brand Name :
No Data Available.
Synonyms :
Class :
Antihypertensive and beta blockers
Dosage Forms & Strengths
tablet
20mg
40mg
80mg
40 - 320
mg
Tablet
Orally
once a day
Initial:
40
mg
Orally
once a day
3 - 7
days
Supraventricular Tachycardia (SVT)
(off-label):
60 - 160
mg
Tablet
Orally
once a day
off-label:
40 - 160
mg
Tablet
Orally
once a day
off-label:
40 - 80
mg
Tablet
Orally
once a day
and can be increased up to 240 mg orally per day
may enhance the anti-hypertensive effect when both drugs are combined
It may enhance the effects when combined with chloroprocaine by pharmacodynamic synergism
it may diminish the excretion rate when combined with gadofosveset, resulting in an enhanced serum level
may enhance the serum concentration
nadolol's toxicity can also be decreased through the pharmacodynamic antagonism action by melatonin
Adverse drug reactions:
Frequency defined
>10%
Drowsiness
Decreased sexual ability
Insomnia
1-10%
Fatigue
Hypotension
Bradycardia
Dizziness
<1%
Cough
Nasal congestion
Abdominal discomfort
Constipation
Nausea
Diarrhea
Frequency Not Defined
Bronchospasm
depression
Pregnancy warnings:
US FDA pregnancy category: C
Breastfeeding warnings:
The release of the drug into the human breastmilk is known
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits
Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: nadolol
Pronounced: NAY-doe-lol
Why do we use nadolol?
nadolol is an anti-hypertensive drug belonging to the subclass beta-blocker used to treat hypertension and angina. It mainly helps in decrease of high blood pressure and prevent risk of heart stroke, heart attacks and renal problems.